Repare Therapeutics Inc (RPTX)
3.67
+0.13
(+3.67%)
USD |
NASDAQ |
Jun 24, 09:39
Repare Therapeutics Shareholders Equity (Quarterly): 231.95M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 231.95M |
| December 31, 2023 | 212.08M |
| September 30, 2023 | 233.37M |
| June 30, 2023 | 245.41M |
| March 31, 2023 | 251.24M |
| December 31, 2022 | 279.52M |
| September 30, 2022 | 305.78M |
| June 30, 2022 | 225.52M |
| March 31, 2022 | 258.66M |
| Date | Value |
|---|---|
| December 31, 2021 | 288.42M |
| September 30, 2021 | 218.25M |
| June 30, 2021 | 245.09M |
| March 31, 2021 | 267.65M |
| December 31, 2020 | 286.83M |
| September 30, 2020 | 300.80M |
| June 30, 2020 | 313.66M |
| March 31, 2020 | -58.14M |
| December 31, 2019 | -46.13M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-58.14M
Minimum
Mar 2020
313.66M
Maximum
Jun 2020
225.55M
Average
248.33M
Median
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
| InMed Pharmaceuticals Inc | 11.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 263.08M |
| Total Liabilities (Quarterly) | 31.13M |
| Current Ratio | 8.331 |